Tech giants like IBM and Google have invested billions internally in A.I. research, but the past few years have also seen a wave of acquisitions, as big companies buy up startups to obtain top talent and new data-crunching science. (Acquisition figures are since 2010. source: CB Insights)
> Google CEO Sundar Pichai has made the case that artificial intelligence is core to the search giant’s major businesses. It definitely shows in its acquisitions, including its 2014 purchase for over $600 million of U.K.–based Deep-Mind—whose software is best known for being the first to defeat a human champion at the strategy game Go (above).
> Apple kicked off its A.I. acquisition spree in 2010 when it bought Siri, whose voice-recognition interface has since become, for many, the embodiment of consumer-facing A.I.
> The social networking giant is also an A.I. heavyweight, using deep learning to clean up its News Feed (though that’s very much a work in progress). Its recent big buys include the 2017 acquisition of Ozlo to improve its messaging app.
> It takes a lot of A.I. to fuel both its online retail (matching products to customer preferences) and its cloud-computing business. Amazon also uses A.I. to help screen the produce it ships through its grocery delivery business.
Image Credit: Go Fans watch a TV screen showing the live broadcast of the Google DeepMind Challenge Match in Seoul, South Korea. Google’s artificial intelligence program AlphaGo beat top-class South Korean Go player Lee Se-dol. Seung Il Ryu—Zuma Wire
News This Week
Shigella bacteria, which causes Shigellosis, is the primary cause of bacterial diarrhea and diarrheal death among juveniles under five years of age. Because of the antibiotic resistance of Shigella strains, no commercial vaccines are available to date. [...]
Scientists have built microscopic robots equipped with electronic “brains” that are capable of walking autonomously. A team from Cornell University in the US developed the solar-powered bots as part of research into a new generation of [...]
Blood samples from patients with long COVID who are still suffering from fatigue and shortness of breath after a year show signs of autoimmune disease, according to a study published today (Thursday) [...]
High-grade serous ovarian cancer (HGSOC) is among the deadliest human cancers and its prognosis remains extremely poor. An article published in Advanced Science explored the self-therapeutic properties of gold nanoparticles to identify a molecular axis that [...]
Antimicrobial peptides (AMPs) have a broad spectrum of antimicrobial activity and lyse microbial cells by interaction with biomembranes, offering great potential in designing new therapeutics. The antimicrobial resistance (AMR) caused due to overuse of [...]
Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now, UC San Francisco researchers have developed a [...]
Hyperspectral microscopy is an advanced visualization technique that combines hyperspectral imaging with state-of-the-art optics and computer software to enable rapid identification of nanomaterials. Since hyperspectral datacubes are large, their acquisition is complicated and time-consuming. [...]
Malignant brain tumors are cancerous growth in the brain with the possibility of spreading to other parts of the central nervous system (CNS). Brain tumors are highly invasive and have devastating consequences, poor prognosis, [...]